BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Manic-Depressive Illness Bipolar Disorder

Below is an extended Manic-Depressive Illness Bipolar Disorder research listing. Click here to return to the Manic-Depressive Illness Bipolar Disorder main in depth entry.

Recent Publications on Manic-Depressive Illness Bipolar Disorder:

Bipolar affective disorder and medication therapy: identifying barriers. 4th October, 2008
Ribeirao Preto College of Nursing, University of Sao Paulo.
Cerebellum and psychiatric disorders. 4th October, 2008
Laboratorio Interdisciplinar de Neurociencias Clinicas, Departamento de
Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. 4th October, 2008
Bipolar Disorders Program and Laboratory of Molecular Psychiatry, Hospital
Staying at the crossroads: assessment of the potential of serum lithium monitoring in predicting an ideal lithium dose. 4th October, 2008
Department of Physiology, Universidade Federal de Sao Paulo, Sao Paulo,
Cognitive impairment in a Brazilian sample of patients with bipolar disorder. 4th October, 2008
Bipolar Disorder Program, Molecular Psychiatry Laboratory, Hospital de
Neuroimaging Studies of Normal Brain Development and Their Relevance for Understanding Childhood Neuropsychiatric Disorders.
OBJECTIVE:: To review the maturational events that occur during prenatal...
Direct Link
4th October, 2008
The authors are with the Division of Child and Adolescent Psychiatry in
Effectiveness and efficiency of cognitive-behavioral group therapy for inpatients: 4-year follow-up study.
OBJECTIVES: The goals of this study were to evaluate the effectiveness of...
Direct Link
4th October, 2008
Dipartimento di Salute Mentale, ASReM, Zona 3 Centro Molise di Campobasso,
Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans.
OBJECTIVE: Although psychological trauma affects millions of Americans,...
Direct Link
4th October, 2008
Department of Psychiatry, Yale University School of Medicine, New Haven,
Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
OBJECTIVE: Because treatments for bipolar disorder include a growing...
Direct Link
4th October, 2008
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004.
OBJECTIVE: This study examined longitudinal trends in the use of mood...
Direct Link
4th October, 2008
Sam and Rose Stein Institute for Research on Aging, University of
Characterization of aripiprazole partial agonist activity at human dopamine D(3) receptors.
Aripiprazole is the first dopamine D(2)/D(3) receptor partial agonist...
Direct Link
4th October, 2008
Quests Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima,
Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial. 3rd October, 2008
Department of Psychiatry, Fontan Hospital CHRU Lille, University of Lille
Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation.
Based on extensive preclinical data, glycogen synthase kinase-3 (GSK-3)...
Direct Link
3rd October, 2008
Center for Translational Medicine, Thomas Jefferson University,
The Role of Interpersonal and Social Rhythm Therapy in Improving Occupational Functioning in Patients With Bipolar I Disorder.
Objective Recent studies demonstrate the poor psychosocial outcomes...
Direct Link
3rd October, 2008
The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?
Bipolar disorder (BD) has been classically described as one of episodic...
Direct Link
2nd October, 2008
Department of Psychiatry, Western Psychiatric Institute and Clinic,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional